nodes	percent_of_prediction	percent_of_DWPC	metapath
Rasagiline—BCL2—neck—thymus cancer	0.0341	0.156	CbGeAlD
Rasagiline—Osteonecrosis—Octreotide—thymus cancer	0.031	0.0438	CcSEcCtD
Rasagiline—VIIth nerve paralysis—Octreotide—thymus cancer	0.0282	0.0398	CcSEcCtD
Rasagiline—BCL2—hematopoietic system—thymus cancer	0.0254	0.116	CbGeAlD
Rasagiline—Hernia—Octreotide—thymus cancer	0.0246	0.0348	CcSEcCtD
Rasagiline—BCL2—epithelium—thymus cancer	0.0232	0.106	CbGeAlD
Rasagiline—BCL2—lymphoid tissue—thymus cancer	0.0179	0.0819	CbGeAlD
Rasagiline—Intestinal obstruction—Octreotide—thymus cancer	0.017	0.024	CcSEcCtD
Rasagiline—Paranoia—Octreotide—thymus cancer	0.017	0.024	CcSEcCtD
Rasagiline—Neuralgia—Octreotide—thymus cancer	0.0166	0.0235	CcSEcCtD
Rasagiline—BCL2—bone marrow—thymus cancer	0.0163	0.0746	CbGeAlD
Rasagiline—BCL2—thyroid gland—thymus cancer	0.0162	0.0744	CbGeAlD
Rasagiline—Neuritis—Octreotide—thymus cancer	0.0155	0.0219	CcSEcCtD
Rasagiline—BCL2—lung—thymus cancer	0.0147	0.0676	CbGeAlD
Rasagiline—Nephrolithiasis—Octreotide—thymus cancer	0.0144	0.0203	CcSEcCtD
Rasagiline—Amenorrhoea—Octreotide—thymus cancer	0.0132	0.0186	CcSEcCtD
Rasagiline—Arthropathy—Octreotide—thymus cancer	0.0127	0.018	CcSEcCtD
Rasagiline—Drug interaction—Octreotide—thymus cancer	0.0125	0.0176	CcSEcCtD
Rasagiline—Vaginal inflammation—Octreotide—thymus cancer	0.0116	0.0163	CcSEcCtD
Rasagiline—Vaginal infection—Octreotide—thymus cancer	0.0109	0.0154	CcSEcCtD
Rasagiline—Neuropathy—Octreotide—thymus cancer	0.0108	0.0153	CcSEcCtD
Rasagiline—Cramps of lower extremities—Octreotide—thymus cancer	0.0106	0.015	CcSEcCtD
Rasagiline—MAOB—hematopoietic system—thymus cancer	0.0106	0.0485	CbGeAlD
Rasagiline—Mouth ulceration—Octreotide—thymus cancer	0.0104	0.0148	CcSEcCtD
Rasagiline—Urine output increased—Octreotide—thymus cancer	0.0104	0.0148	CcSEcCtD
Rasagiline—Gynaecomastia—Octreotide—thymus cancer	0.0103	0.0146	CcSEcCtD
Rasagiline—Hyperkinesia—Octreotide—thymus cancer	0.0101	0.0142	CcSEcCtD
Rasagiline—BCL2—lymph node—thymus cancer	0.0101	0.0462	CbGeAlD
Rasagiline—Phlebitis—Octreotide—thymus cancer	0.00974	0.0138	CcSEcCtD
Rasagiline—Thrombophlebitis—Octreotide—thymus cancer	0.00969	0.0137	CcSEcCtD
Rasagiline—Polyuria—Octreotide—thymus cancer	0.00955	0.0135	CcSEcCtD
Rasagiline—Gastroenteritis—Octreotide—thymus cancer	0.00946	0.0134	CcSEcCtD
Rasagiline—Deafness—Octreotide—thymus cancer	0.00938	0.0133	CcSEcCtD
Rasagiline—Injury—Octreotide—thymus cancer	0.00913	0.0129	CcSEcCtD
Rasagiline—Amnesia—Octreotide—thymus cancer	0.00893	0.0126	CcSEcCtD
Rasagiline—Arthritis—Octreotide—thymus cancer	0.00863	0.0122	CcSEcCtD
Rasagiline—Osteoarthritis—Octreotide—thymus cancer	0.00839	0.0119	CcSEcCtD
Rasagiline—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00839	0.0119	CcSEcCtD
Rasagiline—Psychotic disorder—Octreotide—thymus cancer	0.00819	0.0116	CcSEcCtD
Rasagiline—MAOB—cardiac atrium—thymus cancer	0.00802	0.0368	CbGeAlD
Rasagiline—MAOB—pituitary gland—thymus cancer	0.00783	0.0359	CbGeAlD
Rasagiline—CYP1A2—hematopoietic system—thymus cancer	0.00752	0.0345	CbGeAlD
Rasagiline—Muscular weakness—Octreotide—thymus cancer	0.0074	0.0105	CcSEcCtD
Rasagiline—Influenza—Octreotide—thymus cancer	0.00725	0.0102	CcSEcCtD
Rasagiline—Asthma—Octreotide—thymus cancer	0.00725	0.0102	CcSEcCtD
Rasagiline—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CYLD—thymus cancer	0.00688	0.0924	CbGpPWpGaD
Rasagiline—Dysuria—Octreotide—thymus cancer	0.00678	0.00958	CcSEcCtD
Rasagiline—MAOB—thyroid gland—thymus cancer	0.00675	0.031	CbGeAlD
Rasagiline—Upper respiratory tract infection—Octreotide—thymus cancer	0.00674	0.00952	CcSEcCtD
Rasagiline—Pollakiuria—Octreotide—thymus cancer	0.0067	0.00946	CcSEcCtD
Rasagiline—Weight decreased—Octreotide—thymus cancer	0.00656	0.00927	CcSEcCtD
Rasagiline—Depression—Octreotide—thymus cancer	0.00645	0.00911	CcSEcCtD
Rasagiline—Neuropathy peripheral—Octreotide—thymus cancer	0.00634	0.00895	CcSEcCtD
Rasagiline—Jaundice—Octreotide—thymus cancer	0.0063	0.0089	CcSEcCtD
Rasagiline—Conjunctivitis—Octreotide—thymus cancer	0.00628	0.00888	CcSEcCtD
Rasagiline—Haematuria—Octreotide—thymus cancer	0.00616	0.00871	CcSEcCtD
Rasagiline—MAOB—lung—thymus cancer	0.00613	0.0281	CbGeAlD
Rasagiline—Epistaxis—Octreotide—thymus cancer	0.0061	0.00862	CcSEcCtD
Rasagiline—Rhinitis—Octreotide—thymus cancer	0.00582	0.00822	CcSEcCtD
Rasagiline—Hypoaesthesia—Octreotide—thymus cancer	0.00577	0.00816	CcSEcCtD
Rasagiline—Oedema peripheral—Octreotide—thymus cancer	0.00572	0.00808	CcSEcCtD
Rasagiline—Cardiac disorder—Octreotide—thymus cancer	0.00539	0.00761	CcSEcCtD
Rasagiline—Immune system disorder—Octreotide—thymus cancer	0.00524	0.00741	CcSEcCtD
Rasagiline—Alopecia—Octreotide—thymus cancer	0.00513	0.00725	CcSEcCtD
Rasagiline—Mental disorder—Octreotide—thymus cancer	0.00508	0.00718	CcSEcCtD
Rasagiline—Malnutrition—Octreotide—thymus cancer	0.00505	0.00714	CcSEcCtD
Rasagiline—Flatulence—Octreotide—thymus cancer	0.00498	0.00703	CcSEcCtD
Rasagiline—Back pain—Octreotide—thymus cancer	0.00489	0.0069	CcSEcCtD
Rasagiline—Muscle spasms—Octreotide—thymus cancer	0.00486	0.00686	CcSEcCtD
Rasagiline—CYP1A2—thyroid gland—thymus cancer	0.00481	0.0221	CbGeAlD
Rasagiline—Tremor—Octreotide—thymus cancer	0.00473	0.00669	CcSEcCtD
Rasagiline—Ill-defined disorder—Octreotide—thymus cancer	0.00469	0.00662	CcSEcCtD
Rasagiline—Anaemia—Octreotide—thymus cancer	0.00467	0.0066	CcSEcCtD
Rasagiline—Agitation—Octreotide—thymus cancer	0.00464	0.00656	CcSEcCtD
Rasagiline—Malaise—Octreotide—thymus cancer	0.00456	0.00644	CcSEcCtD
Rasagiline—Vertigo—Octreotide—thymus cancer	0.00454	0.00641	CcSEcCtD
Rasagiline—Syncope—Octreotide—thymus cancer	0.00453	0.0064	CcSEcCtD
Rasagiline—Loss of consciousness—Octreotide—thymus cancer	0.00444	0.00627	CcSEcCtD
Rasagiline—BCL2—TP53 Network—CDKN2A—thymus cancer	0.00444	0.0597	CbGpPWpGaD
Rasagiline—Cough—Octreotide—thymus cancer	0.00441	0.00623	CcSEcCtD
Rasagiline—Convulsion—Octreotide—thymus cancer	0.00438	0.00618	CcSEcCtD
Rasagiline—CYP1A2—lung—thymus cancer	0.00437	0.02	CbGeAlD
Rasagiline—Hypertension—Octreotide—thymus cancer	0.00436	0.00616	CcSEcCtD
Rasagiline—Arthralgia—Octreotide—thymus cancer	0.0043	0.00608	CcSEcCtD
Rasagiline—Chest pain—Octreotide—thymus cancer	0.0043	0.00608	CcSEcCtD
Rasagiline—Anxiety—Octreotide—thymus cancer	0.00429	0.00606	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00427	0.00604	CcSEcCtD
Rasagiline—Discomfort—Octreotide—thymus cancer	0.00425	0.006	CcSEcCtD
Rasagiline—Dry mouth—Octreotide—thymus cancer	0.00421	0.00594	CcSEcCtD
Rasagiline—MAOB—lymph node—thymus cancer	0.00419	0.0192	CbGeAlD
Rasagiline—Infection—Octreotide—thymus cancer	0.0041	0.00579	CcSEcCtD
Rasagiline—Shock—Octreotide—thymus cancer	0.00406	0.00573	CcSEcCtD
Rasagiline—Nervous system disorder—Octreotide—thymus cancer	0.00404	0.00571	CcSEcCtD
Rasagiline—Skin disorder—Octreotide—thymus cancer	0.004	0.00566	CcSEcCtD
Rasagiline—Hyperhidrosis—Octreotide—thymus cancer	0.00399	0.00563	CcSEcCtD
Rasagiline—Anorexia—Octreotide—thymus cancer	0.00393	0.00555	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00376	0.00531	CcSEcCtD
Rasagiline—Insomnia—Octreotide—thymus cancer	0.00373	0.00527	CcSEcCtD
Rasagiline—Paraesthesia—Octreotide—thymus cancer	0.0037	0.00523	CcSEcCtD
Rasagiline—Dyspnoea—Octreotide—thymus cancer	0.00368	0.00519	CcSEcCtD
Rasagiline—Somnolence—Octreotide—thymus cancer	0.00367	0.00518	CcSEcCtD
Rasagiline—Dyspepsia—Octreotide—thymus cancer	0.00363	0.00513	CcSEcCtD
Rasagiline—Decreased appetite—Octreotide—thymus cancer	0.00358	0.00506	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Octreotide—thymus cancer	0.00356	0.00503	CcSEcCtD
Rasagiline—Constipation—Octreotide—thymus cancer	0.00353	0.00498	CcSEcCtD
Rasagiline—Feeling abnormal—Octreotide—thymus cancer	0.0034	0.0048	CcSEcCtD
Rasagiline—Gastrointestinal pain—Octreotide—thymus cancer	0.00337	0.00476	CcSEcCtD
Rasagiline—Urticaria—Octreotide—thymus cancer	0.00328	0.00463	CcSEcCtD
Rasagiline—Body temperature increased—Octreotide—thymus cancer	0.00326	0.00461	CcSEcCtD
Rasagiline—Abdominal pain—Octreotide—thymus cancer	0.00326	0.00461	CcSEcCtD
Rasagiline—Hypersensitivity—Octreotide—thymus cancer	0.00304	0.00429	CcSEcCtD
Rasagiline—Asthenia—Octreotide—thymus cancer	0.00296	0.00418	CcSEcCtD
Rasagiline—Pruritus—Octreotide—thymus cancer	0.00292	0.00412	CcSEcCtD
Rasagiline—Diarrhoea—Octreotide—thymus cancer	0.00282	0.00399	CcSEcCtD
Rasagiline—Dizziness—Octreotide—thymus cancer	0.00273	0.00385	CcSEcCtD
Rasagiline—BCL2—IL2 signaling events mediated by STAT5—IL2—thymus cancer	0.00267	0.0359	CbGpPWpGaD
Rasagiline—Vomiting—Octreotide—thymus cancer	0.00262	0.0037	CcSEcCtD
Rasagiline—Rash—Octreotide—thymus cancer	0.0026	0.00367	CcSEcCtD
Rasagiline—Dermatitis—Octreotide—thymus cancer	0.0026	0.00367	CcSEcCtD
Rasagiline—Headache—Octreotide—thymus cancer	0.00258	0.00365	CcSEcCtD
Rasagiline—BCL2—Activation of BAD and translocation to mitochondria—AKT1—thymus cancer	0.00252	0.0339	CbGpPWpGaD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—KIT—thymus cancer	0.00248	0.0334	CbGpPWpGaD
Rasagiline—BCL2—TP53 Network—TP53—thymus cancer	0.00247	0.0332	CbGpPWpGaD
Rasagiline—Nausea—Octreotide—thymus cancer	0.00245	0.00346	CcSEcCtD
Rasagiline—BCL2—IL2 signaling events mediated by PI3K—IL2—thymus cancer	0.00226	0.0304	CbGpPWpGaD
Rasagiline—BCL2—Kit receptor signaling pathway—KIT—thymus cancer	0.00221	0.0297	CbGpPWpGaD
Rasagiline—BCL2—IL-5 Signaling Pathway—IL2—thymus cancer	0.00212	0.0285	CbGpPWpGaD
Rasagiline—BCL2—IL-2 Signaling Pathway—IL2—thymus cancer	0.00204	0.0274	CbGpPWpGaD
Rasagiline—BCL2—Activation of BH3-only proteins—TP53—thymus cancer	0.00198	0.0267	CbGpPWpGaD
Rasagiline—BCL2—Estrogen signaling pathway—AKT1—thymus cancer	0.00179	0.0241	CbGpPWpGaD
Rasagiline—BCL2—Activation of BH3-only proteins—AKT1—thymus cancer	0.00168	0.0225	CbGpPWpGaD
Rasagiline—BCL2—IL2-mediated signaling events—IL2—thymus cancer	0.00167	0.0224	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—KIT—thymus cancer	0.00167	0.0224	CbGpPWpGaD
Rasagiline—BCL2—Intrinsic Pathway for Apoptosis—TP53—thymus cancer	0.00142	0.0191	CbGpPWpGaD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—TP53—thymus cancer	0.00142	0.0191	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—CDKN2A—thymus cancer	0.00135	0.0182	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—CDKN2A—thymus cancer	0.00135	0.0182	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—CD4—thymus cancer	0.00127	0.0171	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—CDKN2A—thymus cancer	0.00127	0.017	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—TP53—thymus cancer	0.00126	0.017	CbGpPWpGaD
Rasagiline—BCL2—IL2 signaling events mediated by PI3K—AKT1—thymus cancer	0.00122	0.0165	CbGpPWpGaD
Rasagiline—BCL2—Intrinsic Pathway for Apoptosis—AKT1—thymus cancer	0.0012	0.0161	CbGpPWpGaD
Rasagiline—BCL2—IL-5 Signaling Pathway—AKT1—thymus cancer	0.00115	0.0155	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—CDKN2A—thymus cancer	0.00113	0.0152	CbGpPWpGaD
Rasagiline—BCL2—IL-2 Signaling Pathway—AKT1—thymus cancer	0.00111	0.0149	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—CDKN2A—thymus cancer	0.0011	0.0148	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—IL2—thymus cancer	0.00109	0.0146	CbGpPWpGaD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—AKT1—thymus cancer	0.00107	0.0143	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—AKT1—thymus cancer	0.00107	0.0143	CbGpPWpGaD
Rasagiline—BCL2—Ceramide signaling pathway—AKT1—thymus cancer	0.000994	0.0134	CbGpPWpGaD
Rasagiline—BCL2—IL-3 Signaling Pathway—AKT1—thymus cancer	0.000978	0.0131	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CYLD—thymus cancer	0.000972	0.0131	CbGpPWpGaD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—AKT1—thymus cancer	0.000947	0.0127	CbGpPWpGaD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—AKT1—thymus cancer	0.000866	0.0116	CbGpPWpGaD
Rasagiline—BCL2—Kit receptor signaling pathway—AKT1—thymus cancer	0.000843	0.0113	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TP53—thymus cancer	0.000752	0.0101	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—TP53—thymus cancer	0.000706	0.00949	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—AKT1—thymus cancer	0.000635	0.00854	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—TP53—thymus cancer	0.000629	0.00846	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—TP53—thymus cancer	0.000611	0.00821	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—AKT1—thymus cancer	0.000591	0.00794	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CYLD—thymus cancer	0.000566	0.00761	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—AKT1—thymus cancer	0.000516	0.00693	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—TP53—thymus cancer	0.0005	0.00672	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—TP53—thymus cancer	0.000471	0.00633	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TP53—thymus cancer	0.000461	0.0062	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—thymus cancer	0.000452	0.00607	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—AKT1—thymus cancer	0.000397	0.00534	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	0.00039	0.00524	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—AKT1—thymus cancer	0.000389	0.00523	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—KIT—thymus cancer	0.000356	0.00479	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—AKT1—thymus cancer	0.000331	0.00445	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	0.000329	0.00443	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CD8A—thymus cancer	0.000276	0.00372	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CD4—thymus cancer	0.000273	0.00366	CbGpPWpGaD
Rasagiline—BCL2—Immune System—KIT—thymus cancer	0.000208	0.00279	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CD4—thymus cancer	0.000159	0.00213	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL2—thymus cancer	0.000146	0.00196	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—AKT1—thymus cancer	0.000136	0.00183	CbGpPWpGaD
Rasagiline—BCL2—Immune System—AKT1—thymus cancer	7.92e-05	0.00106	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—AKT1—thymus cancer	6.3e-05	0.000847	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—AKT1—thymus cancer	1.46e-05	0.000196	CbGpPWpGaD
